CVS Caremark expands access to GLP-1 weight management drugs
The company continues to launch innovative digital offerings to help members access care, as part of its $20 billion technology investment, announced in 2025.
CVS Caremark
CVS Caremark expands biosimilar adoption through formulary updates
New changes expected to deliver significant client savings while maintaining rigorous clinical standards.
CVS Caremark’s Clinical Pipeline Services: Four drugs that could change care this spring
CVS Caremark’s Clinical Pipeline Services team tracks what’s ahead by translating complex drug approvals into practical information about what may matter for patient care.
CVS to Tennessee: The legislation is tone deaf
CVS would have to close or sell its outlets in Nashville, and the rest of Tennessee, if state legislation barring ownership of pharmacies by PBMs becomes state law.
CVS Caremark advances prior authorization to get specialty medications to patients faster
Innovative technology can reduce prior authorization process time and improves patient care.
Market shows that Caremark is 'on the right path'
Losing the Eli Lilly contract is insignficant, given that ‘the dollars barely move.’
CVS Caremark must pay $95M in Medicare fraud case
Eastern District of Pennsylvania Judge Mitchell Goldberg ruled that Caremark inflated Medicare Part D prices to offset other costs.